ArticleCancers2020

Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer.

Bruna Cerbelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.